{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:32:02Z","timestamp":1790688722150,"version":"4.1.0"},"reference-count":25,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00444","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T01:10:01Z","timestamp":1507684201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux\u2014A Prospective Longitudinal Interventional Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Christoph","family":"Castellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kashofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Huber-Zeyringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Flucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Till","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/1462-2920.12285","article-title":"Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors","volume":"16","author":"Amir","year":"2014","journal-title":"Environ. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"20873","DOI":"10.2807\/1560-7917.ES2014.19.32.20873","article-title":"Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use - an ecological study","volume":"19","author":"Bouwknegt","year":"2014","journal-title":"Euro Surveill."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/0009922815569201","article-title":"Acid-suppressing agents and risk for Clostridium difficile infection in pediatric patients","volume":"54","author":"Brown","year":"2015","journal-title":"Clin. Pediatr. (Phila)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00383-013-3458-6","article-title":"Proton pump inhibitors for reflux therapy in infants: effectiveness determined by impedance pH monitoring","volume":"30","author":"Castellani","year":"2014","journal-title":"Pediatr. Surg. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.13568","article-title":"A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors","volume":"43","author":"Clooney","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00005176-200311001-00003","article-title":"Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy","volume":"37","author":"Colletti","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/ajg.2016.343","article-title":"Proton pump inhibitors do not increase risk for Clostridium difficile infection in the intensive care unit","volume":"111","author":"Faleck","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/cid\/civ432","article-title":"Use of acid suppression medication is associated with risk for c. difficile infection in infants and children: a population-based study","volume":"61","author":"Freedberg","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg","year":"","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1021\/pr3006364","article-title":"Metaproteome analysis and molecular genetics of rat intestinal microbiota reveals section and localization resolved species distribution and enzymatic functionalities","volume":"11","author":"Haange","year":"2012","journal-title":"J. Proteome Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40168-016-0213-y","article-title":"Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort","volume":"5","author":"Hill","year":"2017","journal-title":"Microbiome"},{"key":"B13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/B978-0-323-07255-7.00073-8","article-title":"Gastroesophageal Reflux Disease","volume-title":"Pediatric Surgery","author":"Hollwarth","year":"2012"},{"key":"B14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3389\/fmicb.2016.02012","article-title":"16S based microbiome analysis from healthy subjects' skin swabs stored for different storage periods reveal phylum to genus level changes","volume":"7","author":"Klymiuk","year":"2016","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile Infection","volume":"373","author":"Leffler","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamainternmed.2015.42","article-title":"Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection","volume":"175","author":"McDonald","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pbio.0050177","article-title":"Development of the human infant intestinal microbiota","volume":"5","author":"Palmer","year":"2007","journal-title":"PLoS Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00005176-200100002-00001","article-title":"Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition","volume":"32","author":"Rudolph","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1651-2227.2007.00306.x","article-title":"Gastro-oesophageal reflux disease: oesophageal impedance versus pH monitoring","volume":"96","author":"Vandenplas","year":"2007","journal-title":"Acta Paediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/138920009787048392","article-title":"The effect of proton pump inhibitors on the human microbiota","volume":"10","author":"Vesper","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T01:10:04Z","timestamp":1507684204000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":25,"alternative-id":["10.3389\/fcimb.2017.00444"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00444","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]},"article-number":"444"}}